These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32848902)

  • 1. Cannabis Improves Obsessive-Compulsive Disorder-Case Report and Review of the Literature.
    Szejko N; Fremer C; Müller-Vahl KR
    Front Psychiatry; 2020; 11():681. PubMed ID: 32848902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the Diagnosis and Assessment in Patients with Tourette Syndrome and Comorbid Obsessive-Compulsive Disorder.
    Szejko N; Müller-Vahl KR
    Neuropsychiatr Dis Treat; 2021; 17():1253-1266. PubMed ID: 33958867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.
    Kayser RR; Haney M; Raskin M; Arout C; Simpson HB
    Depress Anxiety; 2020 Aug; 37(8):801-811. PubMed ID: 32383271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey.
    Milosev LM; Psathakis N; Szejko N; Jakubovski E; Müller-Vahl KR
    Cannabis Cannabinoid Res; 2019; 4(4):265-274. PubMed ID: 31872061
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome.
    Müller-Vahl KR; Bindila L; Lutz B; Musshoff F; Skripuletz T; Baumgaertel C; Sühs KW
    Neuropsychopharmacology; 2020 Jul; 45(8):1323-1329. PubMed ID: 32272483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome.
    Rothenberger A; Roessner V
    Curr Neuropharmacol; 2019; 17(8):703-709. PubMed ID: 30152283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics.
    Petter T; Richter MA; Sandor P
    J Clin Psychiatry; 1998 Sep; 59(9):456-9. PubMed ID: 9771815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.
    Diniz JB; Rosario-Campos MC; Hounie AG; Curi M; Shavitt RG; Lopes AC; Miguel EC
    J Psychiatr Res; 2006 Sep; 40(6):487-93. PubMed ID: 16289552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment-refractory OCD from the viewpoint of obsessive-compulsive spectrum disorders: impact of comorbid child and adolescent psychiatric disorders].
    Kano Y
    Seishin Shinkeigaku Zasshi; 2013; 115(9):990-6. PubMed ID: 24228477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.
    Nordstrom EJ; Burton FH
    Mol Psychiatry; 2002; 7(6):617-25, 524. PubMed ID: 12140785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center.
    Sambrani T; Jakubovski E; Müller-Vahl KR
    Front Neurosci; 2016; 10():415. PubMed ID: 27672357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of tic-related obsessive-compulsive disorder: results from a large multicenter study.
    Gomes de Alvarenga P; de Mathis MA; Dominguez Alves AC; do Rosário MC; Fossaluza V; Hounie AG; Miguel EC; Rodrigues Torres A
    CNS Spectr; 2012 Jun; 17(2):87-93. PubMed ID: 22789066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; Landman AD; van Kempen GM
    J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate?
    Cath DC; Spinhoven P; van Woerkom TC; van de Wetering BJ; Hoogduin CA; Landman AD; Roos RA; Rooijmans HG
    J Nerv Ment Dis; 2001 Apr; 189(4):219-28. PubMed ID: 11339317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comorbid disorders associated with tics].
    Fernández-Alvarez E
    Rev Neurol; 2002 Feb; 34 Suppl 1():S122-9. PubMed ID: 12447802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome.
    Gerasch S; Kanaan AS; Jakubovski E; Müller-Vahl KR
    Front Neurosci; 2016; 10():416. PubMed ID: 27672358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?
    Kayser RR; Snorrason I; Haney M; Lee FS; Simpson HB
    Cannabis Cannabinoid Res; 2019; 4(2):77-87. PubMed ID: 32656342
    [No Abstract]   [Full Text] [Related]  

  • 20. Obsessive-compulsive disorder in Tourette's syndrome.
    Como PG; LaMarsh J; O'Brien KA
    Adv Neurol; 2005; 96():249-61. PubMed ID: 16383224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.